We work with global life science organisations - empowering them to reach their decarbonisation targets ahead of promised deadlines through our unique 3C approach.
EECO2 is trusted by the world’s largest pharmaceutical companies to design and implement carbon and cost reduction strategies whilst maintaining or improving quality and compliance.
Since 2020, we’ve discovered thousands of carbon optimisation projects across hundreds of pharma sites for a broad range of life science clients – totalling over 160,000 tonnes of CO2 reduction.
We promise to do the same for your organisation.
Learn More About EECO2Click to find out more:
Our 3C assessment process gives you clarity on where to start and what to prioritise to achieve your organisation’s sustainability objectives.
We engage with key stakeholders every step of the way, ensuring quality is at the centre of every conversation.
Read About Our 3C Assessments
We can take your initial idea(s) and develop this into a ready-to-implement solution through our series of end-to-end design services.
At every stage, we apply best practice engineering to your complex operations – maximising the sustainability potential of your life science site.
See Our Range of Design Services
It’s more than possible to lower cleanroom airflow rates without harming room performance.
In fact, through our adaptive demand-based control, we not only guarantee a compliant space at all times, we also deliver proven energy reduction of up to 70%!
Read About The World's First Dynamic Cleanroom Control System
Our Design & Build service brings modern advancements to your next cleanroom facility, delivering guaranteed energy efficiency.
With almost two decades of experience and expertise in efficient AHU design, we ensure your life science cleanroom is built to the latest in sustainability best practice.
Explore Our Low Energy Cleanrooms
Our consultancy services focus on delivering transformative outcomes for our clients and the planet.
By using an integrated and cooperative approach to deliver trusted guidance, life science organisations are able to understand bespoke solutions to their unique problems.
Find out more
The pharmaceutical industry is responding to the challenge of global warming by reviewing its impact throughout its operations and value chain. In doing this, global life science organisations are setting rapidly approaching decarbonisation targets that will deliver a more sustainable pharma industry within a decade.
Yet the road to net-zero carbon is uncertain. Opportunities to decarbonise are not always obvious, and their wider impact on the business can be hard to understand.
Our extensive experience in net-zero strategy and delivery, identification of optimal decarbonisation and energy reduction opportunities alongside the application of engineering best practice means we are ideally placed to provide guidance and collaboration toward the net-zero future you are striving for.
Find out more
Once potential projects have been selected from an initial energy assessment, water assessment or ESOS report, we will produce a study that develops a detailed solution. This feasibility study will include concept designs, risk assessments and detailed costs and savings to enable you to fund and implement projects.
Our services in this area include:
GSK
AstraZeneca
Pfizer
Takeda
Bayer
Moderna
Sanofi
Haleon
Lonza
Thermofisher
Kite Pharma
Gilead Sciences
Novartis
Ipsen
Engage with an EECO2 Expert Today
Bring your sustainability questions and we’ll find the answers. We’re always on hand to support your net zero journey, every step of the way.
© Copyright 2023 EECO2
Created by Summit Creative
